Riskpilot← Back to searchSign inGet full accessCurenc AB
ABActiveOrg 5592735137Sunnorpsgatan 5Patent brokering and marketing service activities · NACE 7491Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
+69% vs 2023
Equity ratio
97.0%
Financial strength
Net profit 2024
SEK -12K
+74% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -14K | +69% |
| Net profit | SEK -12K | +74% |
| Total assets | SEK 1,5M | +72% |
| Equity | SEK 1,5M | +3302% |
| Employees | 0 | — |
Legal name
Curenc AB
Org number
5592735137
Legal form
Aktiebolag
NACE code
7491 · Patent brokering and marketing service activities
Founded
25 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget har till föremål för sin verksamhet att äga och förvalta patent, immateriella rättigheter och därmed förenlig verksamhet.
Address
Sunnorpsgatan 5
Email
petter.sivler@s2m.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −14 | −2 | −45 | −14 |
| Depreciation & amort. | −0 | — | — | −0 |
| EBIT | −14 | −2 | −45 | −14 |
| Net financials | — | −0 | −0 | 1 |
| Profit before tax | −14 | −2 | −45 | −12 |
| Tax | −0 | — | — | −0 |
| Net profit | −14 | −2 | −45 | −12 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 28 | 390 | 900 | 1 545 |
| Equity | 11 | 89 | 44 | 1 498 |
| Long-term debt | 0 | — | — | 0 |
| Short-term debt | 17 | 300 | 856 | 47 |
| Total debt | 17 | 300 | 856 | 47 |
EBITDA margin
-1400000.0%
This company
15.8%
Market median
-8860859% vs market
20212024
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20212024
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20212024
Net profit margin
-1200000.0%
This company
8.1%
Market median
-14814915% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
S2Medical AB (publ)
Curenc AB Board members of Curenc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Göran Fredrik Skog | Deputy Board Member | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Hazem Khalaf | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Torbjörn Hans Ingvar Bengtsson | Board of Directors | 0 companies |
| Inge Petter Sivlér | Board of Directors | 0 companies |